or   Contact: Randi Appelbaum/DMS at 212-727-1802 or e-mail at RandiA@dmswire.com

WORLD AIDS DAY

OraQuick Rapid HIV-1 Antibody Test
Highlight of World AIDS Day:

- CDC Committed Additional $2 Million for Purchase of OraQuick® Rapid HIV-1 Antibody Tests
- OraSure Opened NASDAQ Stock Market on December 1st, World AIDS Day

FOOTAGE:
B-roll: - Rapid HIV testing/counseling with OraQuick footage; OraQuick Rapid HIV test procedure; shots of OraQuick® Test; counselling at Whitman-Walker Clinic (Washington, D.C.)

Footage includes:
Mike Gausling, CEO, OraSure Technologies (comments at NASDAQ opening)
Ambassador Jack Chow, M.D., Deputy Assistant Secretary for Health and Science, U.S. State Department; William H. Gimson, III, COO, Centers for Disease Control and Prevention

WHO: OraSure Technologies, Inc. (Nasdaq: OSUR), manufacturer of the OraQuick Rapid HIV-1 Antibody Test

WHAT: In honor of World AIDS Day, an annual event created to bring knowledge and awareness of HIV to people across the world, OraSure announces a purchase of $2 million in OraQuick tests by the CDC and opens The NASDAQ Stock Market. OraSure Technologies is the manufacturer of the OraQuick® Rapid HIV-1 Antibody Test, the first and only rapid, point-of-care test approved by the FDA to detect antibodies to HIV-1 in fingerstick and venipuncture whole blood specimens within approximately 20 minutes.